<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Faith Osier</style></author></authors><tertiary-authors><author><style face="normal" font="default" size="100%">Jenny P Y Ting</style></author></tertiary-authors><subsidiary-authors><author><style face="normal" font="default" size="100%">John Fraser</style></author><author><style face="normal" font="default" size="100%">Bart N Lambrecht</style></author><author><style face="normal" font="default" size="100%">Marta Romano</style></author><author><style face="normal" font="default" size="100%">Ricardo T Gazzinelli</style></author><author><style face="normal" font="default" size="100%">Karina R Bortoluci</style></author><author><style face="normal" font="default" size="100%">Dario S Zamboni</style></author><author><style face="normal" font="default" size="100%">Arne N Akbar</style></author><author><style face="normal" font="default" size="100%">Jennie Evans</style></author><author><style face="normal" font="default" size="100%">Doug E Brown</style></author><author><style face="normal" font="default" size="100%">Kamala D Patel</style></author><author><style face="normal" font="default" size="100%">Wu, Yuzhang</style></author><author><style face="normal" font="default" size="100%">Ana B Perez</style></author><author><style face="normal" font="default" size="100%">Oliver Pérez</style></author><author><style face="normal" font="default" size="100%">Thomas Kamradt</style></author><author><style face="normal" font="default" size="100%">Christine Falk</style></author><author><style face="normal" font="default" size="100%">Mira Barda-Saad</style></author><author><style face="normal" font="default" size="100%">Ariel, Amiram</style></author><author><style face="normal" font="default" size="100%">Angela Santoni</style></author><author><style face="normal" font="default" size="100%">Francesco Annunziato</style></author><author><style face="normal" font="default" size="100%">Marco A Cassatella</style></author><author><style face="normal" font="default" size="100%">Hiroshi Kiyono</style></author><author><style face="normal" font="default" size="100%">Valeriy Chereshnev</style></author><author><style face="normal" font="default" size="100%">Alioune Dieye</style></author><author><style face="normal" font="default" size="100%">Moustapha Mbow</style></author><author><style face="normal" font="default" size="100%">Babacar Mbengue</style></author><author><style face="normal" font="default" size="100%">Maguette D S Niang</style></author><author><style face="normal" font="default" size="100%">Melinda Suchard</style></author></subsidiary-authors></contributors><titles><title><style face="normal" font="default" size="100%">The global response to the COVID-19 pandemic: how have immunology societies contributed?</style></title><secondary-title><style face="normal" font="default" size="100%">Nat Rev Immunol</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antiviral Agents</style></keyword><keyword><style  face="normal" font="default" size="100%">Betacoronavirus</style></keyword><keyword><style  face="normal" font="default" size="100%">Community-Institutional Relations</style></keyword><keyword><style  face="normal" font="default" size="100%">Coronavirus Infections</style></keyword><keyword><style  face="normal" font="default" size="100%">COVID-19</style></keyword><keyword><style  face="normal" font="default" size="100%">COVID-19 Vaccines</style></keyword><keyword><style  face="normal" font="default" size="100%">Global Health</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">International Cooperation</style></keyword><keyword><style  face="normal" font="default" size="100%">Pandemics</style></keyword><keyword><style  face="normal" font="default" size="100%">Patient Education as Topic</style></keyword><keyword><style  face="normal" font="default" size="100%">Personal Protective Equipment</style></keyword><keyword><style  face="normal" font="default" size="100%">Pneumonia, Viral</style></keyword><keyword><style  face="normal" font="default" size="100%">SARS-CoV-2</style></keyword><keyword><style  face="normal" font="default" size="100%">Severe Acute Respiratory Syndrome</style></keyword><keyword><style  face="normal" font="default" size="100%">Societies, Scientific</style></keyword><keyword><style  face="normal" font="default" size="100%">Viral Vaccines</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2020 Oct</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">20</style></volume><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;The COVID-19 pandemic is shining a spotlight on the field of immunology like never before. To appreciate the diverse ways in which immunologists have contributed, Nature Reviews Immunology invited the president of the International Union of Immunological Societies and the presidents of 15 other national immunology societies to discuss how they and their members responded following the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">10</style></issue></record></records></xml>